A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities
Abstract Glioblastoma remains incurable and recurs in all patients. Here we design and characterize a novel induced-recurrence model in which mice xenografted with primary patient-derived glioma initiating/stem cells (GIC) are treated with a therapeutic regimen closely recapitulating patient standar...
Saved in:
| Main Authors: | Sara Lucchini, James G Nicholson, Xinyu Zhang, Jacob Househam, Yau Mun Lim, Maximilian Mossner, Thomas O Millner, Sebastian Brandner, Trevor Graham, Silvia Marino |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-04-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s44321-025-00237-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma
by: Harald Krenzlin, et al.
Published: (2025-07-01) -
Practice Patterns for Managing Recurrent Glioblastoma Multiforme
by: Jitin Bajaj, et al.
Published: (2024-03-01) -
TREATMENT FOR RECURRENT GLIOBLASTOMA: ARE THERE SUCCESSES?
by: G. I. Kobyakov, et al.
Published: (2015-04-01) -
The rising interest of primary cilia in central nervous system malignancies: A bibliometric and altmetric analysis revealing the growth of a field
by: Erin N. Walker, et al.
Published: (2025-04-01) -
Targeted Deletion in the Basal Body Protein Talpid3 Leads to Loss of Primary Cilia in Embryonic Stem Cells and Defective Lineage-Specific Differentiation
by: Ross Ferguson, et al.
Published: (2024-11-01)